Disitamab (Anti-ERBB2 / HER2 / CD340)

Disitamab (Anti-ERBB2 / HER2 / CD340) is a humanized monoclonal antibody targeting HER2. It can be used in the synthesis of antibody-drug conjugates (ADCs), Disitamab vedotin. The ADC also known by its trade name Aidixi, which used in the treatment of various solid tumors. It combines a monoclonal antibody Disitamab targeting the HER2 receptor with a cytotoxic agent called monomethyl auristatin E (MMAE) by a linker. It has antitumor and antineoplastic activities. MW :144.16 KD. This product is for research use only.

Product Details
Species Reactivity	Human
Host/Isotype	Human IgG1
Class	Monoclonal
Type	Recombinant Antibody
Immunogen	Human ERBB2 / HER2
Clone	Disitamab biosimilar
Conjugate	Unconjugated
Purity	≥ 99%
Molecular Weight	144.16 KD
Protein Concentration	1mg/ml
Storage Condition	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Storage Buffer	100mM Pro-Ac, 20mM Arg-Ac, pH 5.0